{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:07:13Z","timestamp":1793855233972,"version":"4.6.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["573301"],"award-info":[{"award-number":["573301"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"name":"General Maternity Hospital Foundation, Sweden"},{"DOI":"10.13039\/501100008352","name":"Stiftelsen Samariten","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008352","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lilla barnets fond"},{"DOI":"10.13039\/501100007373","name":"Stiftelsen Sven Jerrings Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s40263-022-00908-2","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T12:02:43Z","timestamp":1645876963000},"page":"529-539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2107-0561","authenticated-orcid":false,"given":"Essi","family":"Heinonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"N\u00f6rby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Wide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"K\u00e4ll\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,26]]},"reference":[{"issue":"11","key":"908_CR1","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1111\/bcp.13732","volume":"84","author":"P Damkier","year":"2018","unstructured":"Damkier P, Christensen LS, Broe A. Patterns and predictors for prescription of psychotropics and mood-stabilizing antiepileptics during pregnancy in Denmark 2000\u20132016. Br J Clin Pharmacol. 2018;84(11):2651\u201362. https:\/\/doi.org\/10.1111\/bcp.13732.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"908_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pds.2082","volume":"20","author":"GC Alexander","year":"2011","unstructured":"Alexander GC, Gallagher SA, Mascola A, et al. Increasing off-label use of antipsychotic medications in the United States, 1995\u20132008. Pharmacoepidemiol Drug Saf. 2011;20(2):177\u201384. https:\/\/doi.org\/10.1002\/pds.2082.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"908_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/0004867412466595","volume":"47","author":"CP Stephenson","year":"2013","unstructured":"Stephenson CP, Karanges E, McGregor IS. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry. 2013;47(1):74\u201387. https:\/\/doi.org\/10.1177\/0004867412466595.","journal-title":"Aust N Z J Psychiatry"},{"issue":"11","key":"908_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1176\/appi.ps.201600408","volume":"68","author":"Y Park","year":"2017","unstructured":"Park Y, Huybrechts KF, Cohen JM, et al. Antipsychotic medication use among publicly insured pregnant women in the United States. Psychiatr Serv. 2017;68(11):1112\u20139. https:\/\/doi.org\/10.1176\/appi.ps.201600408.","journal-title":"Psychiatr Serv"},{"issue":"10027","key":"908_CR5","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/s0140-6736(15)00241-x","volume":"387","author":"I Grande","year":"2016","unstructured":"Grande I, Berk M, Birmaher B, et al. Bipolar disorder. Lancet. 2016;387(10027):1561\u201372. https:\/\/doi.org\/10.1016\/s0140-6736(15)00241-x.","journal-title":"Lancet"},{"issue":"3","key":"908_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1517\/eods.3.3.221.31074","volume":"3","author":"S Dodd","year":"2004","unstructured":"Dodd S, Berk M. The pharmacology of bipolar disorder during pregnancy and breastfeeding. Expert Opin Drug Saf. 2004;3(3):221\u20139. https:\/\/doi.org\/10.1517\/eods.3.3.221.31074.","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"908_CR7","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1177\/0004867419847764","volume":"53","author":"AL Schaffer","year":"2019","unstructured":"Schaffer AL, Zoega H, Tran DT, et al. Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics. Aust N Z J Psychiatry. 2019;53(12):1208\u201321. https:\/\/doi.org\/10.1177\/0004867419847764.","journal-title":"Aust N Z J Psychiatry"},{"issue":"2\u20133","key":"908_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","volume":"123","author":"C Rummel-Kluge","year":"2010","unstructured":"Rummel-Kluge C, Komossa K, Schwarz S, et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2010;123(2\u20133):225\u201333. https:\/\/doi.org\/10.1016\/j.schres.2010.07.012.","journal-title":"Schizophr Res"},{"key":"908_CR9","first-page":"23","volume":"455","author":"SD Holder","year":"2017","unstructured":"Holder SD, Edmunds AL, Morgan S. Psychotic and bipolar disorders: antipsychotic drugs. FP Essent. 2017;455:23\u20139.","journal-title":"FP Essent."},{"issue":"7","key":"908_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/archgenpsychiatry.2011.1870","volume":"69","author":"R Bod\u00e9n","year":"2012","unstructured":"Bod\u00e9n R, Lundgren M, Brandt L, et al. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Arch Gen Psychiatry. 2012;69(7):715\u201321. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.1870.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"908_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00737-013-0330-6","volume":"16","author":"S Toh","year":"2013","unstructured":"Toh S, Li Q, Cheetham TC, et al. Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001\u20132007: a population-based study of 585,615 deliveries. Arch Womens Ment Health. 2013;16(2):149\u201357. https:\/\/doi.org\/10.1007\/s00737-013-0330-6.","journal-title":"Arch Womens Ment Health"},{"issue":"9","key":"908_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40264-017-0543-0","volume":"40","author":"L Hirsch","year":"2017","unstructured":"Hirsch L, Yang J, Bresee L, et al. Second-generation antipsychotics and metabolic side effects: a systematic review of population-based studies. Drug Saf. 2017;40(9):771\u201381. https:\/\/doi.org\/10.1007\/s40264-017-0543-0.","journal-title":"Drug Saf"},{"issue":"Suppl. 1","key":"908_CR13","first-page":"32","volume":"69","author":"DC Henderson","year":"2008","unstructured":"Henderson DC, Doraiswamy PM. Prolactin-related and metabolic adverse effects of atypical antipsychotic agents. J Clin Psychiatry. 2008;69(Suppl. 1):32\u201344.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"908_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s2215-0366(19)30416-x","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger T, McCutcheon RA, Vano L, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7(1):64\u201377. https:\/\/doi.org\/10.1016\/s2215-0366(19)30416-x.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"908_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","volume":"16","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep. 2016;16(1):7. https:\/\/doi.org\/10.1007\/s11892-015-0699-x.","journal-title":"Curr Diab Rep"},{"issue":"2","key":"908_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/JCP.0000000000001002","volume":"39","author":"F Uguz","year":"2019","unstructured":"Uguz F. Antipsychotic use during pregnancy and the risk of gestational diabetes mellitus: a systematic review. J Clin Psychopharmacol. 2019;39(2):162\u20137. https:\/\/doi.org\/10.1097\/JCP.0000000000001002.","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl_6","key":"908_CR17","doi-asserted-by":"publisher","first-page":"1975S","DOI":"10.3945\/ajcn.110.001032","volume":"94","author":"C Zhang","year":"2011","unstructured":"Zhang C, Ning Y. Effect of dietary and lifestyle factors on the risk of gestational diabetes: review of epidemiologic evidence. Am J Clin Nutr. 2011;94(Suppl_6):1975S-S1979. https:\/\/doi.org\/10.3945\/ajcn.110.001032.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"908_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12939-017-0715-7","volume":"17","author":"MK Kim","year":"2018","unstructured":"Kim MK, Lee SM, Bae S-H, et al. Socioeconomic status can affect pregnancy outcomes and complications, even with a universal healthcare system. Int J Equity Health. 2018;17(1):2. https:\/\/doi.org\/10.1186\/s12939-017-0715-7.","journal-title":"Int J Equity Health."},{"issue":"1","key":"908_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00228-019-02769-z","volume":"76","author":"M Ellfolk","year":"2020","unstructured":"Ellfolk M, Leinonen MK, Gissler M, et al. Second-generation antipsychotics and pregnancy complications. Eur J Clin Pharmacol. 2020;76(1):107\u201315. https:\/\/doi.org\/10.1007\/s00228-019-02769-z.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2\u20133","key":"908_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.schres.2016.07.023","volume":"176","author":"I Petersen","year":"2016","unstructured":"Petersen I, Sammon CJ, McCrea RL, et al. Risks associated with antipsychotic treatment in pregnancy: comparative cohort studies based on electronic health records. Schizophr Res. 2016;176(2\u20133):349\u201356. https:\/\/doi.org\/10.1016\/j.schres.2016.07.023.","journal-title":"Schizophr Res"},{"issue":"23","key":"908_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20230","volume":"20","author":"I Petersen","year":"2016","unstructured":"Petersen I, McCrea RL, Sammon CJ, et al. Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records. Health Technol Assess. 2016;20(23):1\u2013176. https:\/\/doi.org\/10.3310\/hta20230.","journal-title":"Health Technol Assess"},{"issue":"3","key":"908_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/schbul\/sbn107","volume":"36","author":"S Gentile","year":"2010","unstructured":"Gentile S. Antipsychotic therapy during early and late pregnancy: a systematic review. Schizophr Bull. 2010;36(3):518\u201344. https:\/\/doi.org\/10.1093\/schbul\/sbn107.","journal-title":"Schizophr Bull"},{"issue":"1","key":"908_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/17446651.2018.1476135","volume":"14","author":"S Farahvar","year":"2019","unstructured":"Farahvar S, Walfisch A, Sheiner E. Gestational diabetes risk factors and long-term consequences for both mother and offspring: a literature review. Expert Rev Endocrinol Metab. 2019;14(1):63\u201374. https:\/\/doi.org\/10.1080\/17446651.2018.1476135.","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"4","key":"908_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/JCP.0b013e318295fe12","volume":"33","author":"F Habermann","year":"2013","unstructured":"Habermann F, Fritzsche J, Fuhlbruck F, et al. Atypical antipsychotic drugs and pregnancy outcome: a prospective, cohort study. J Clin Psychopharmacol. 2013;33(4):453\u201362. https:\/\/doi.org\/10.1097\/JCP.0b013e318295fe12.","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"908_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4088\/JCP.v66n0406","volume":"66","author":"K McKenna","year":"2005","unstructured":"McKenna K, Koren G, Tetelbaum M, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 2005;66(4):444\u20139 (quiz 546).","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"908_CR26","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","volume":"164","author":"DJ Newport","year":"2007","unstructured":"Newport DJ, Calamaras MR, DeVane CL, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry. 2007;164(8):1214\u201320. https:\/\/doi.org\/10.1176\/appi.ajp.2007.06111886.","journal-title":"Am J Psychiatry"},{"issue":"19","key":"908_CR27","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/nejmoa0707943","volume":"358","author":"BE Metzger","year":"2008","unstructured":"HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991\u20132002. https:\/\/doi.org\/10.1056\/nejmoa0707943.","journal-title":"N Engl J Med"},{"issue":"1","key":"908_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2393-9-53","volume":"9","author":"M Persson","year":"2009","unstructured":"Persson M, Winkvist A, Mogren I. Surprisingly low compliance to local guidelines for risk factor based screening for gestational diabetes mellitus: a population-based study. BMC Pregnancy Childbirth. 2009;9(1):53. https:\/\/doi.org\/10.1186\/1471-2393-9-53.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"908_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/aogs.12340","volume":"93","author":"C Ignell","year":"2014","unstructured":"Ignell C, Claesson R, Anderberg E, et al. Trends in the prevalence of gestational diabetes mellitus in southern Sweden, 2003\u20132012. Acta Obstet Gynecol Scand. 2014;93(4):420\u20134. https:\/\/doi.org\/10.1111\/aogs.12340.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"908_CR30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1176\/appi.ajp.2018.17040393","volume":"175","author":"Y Park","year":"2018","unstructured":"Park Y, Hernandez-Diaz S, Bateman BT, et al. Continuation of atypical antipsychotic medication during early pregnancy and the risk of gestational diabetes. Am J Psychiatry. 2018;175(6):564\u201374. https:\/\/doi.org\/10.1176\/appi.ajp.2018.17040393.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"908_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/ajo.12621","volume":"57","author":"J Frayne","year":"2017","unstructured":"Frayne J, Nguyen T, Bennett K, et al. The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness. Aust N Z J Obstet Gynaecol. 2017;57(5):526\u201332. https:\/\/doi.org\/10.1111\/ajo.12621.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"908_CR32","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/pds.3749","volume":"24","author":"F Bellet","year":"2015","unstructured":"Bellet F, Beyens MN, Bernard N, et al. Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study. Pharmacoepidemiol Drug Saf. 2015;24(4):368\u201380. https:\/\/doi.org\/10.1002\/pds.3749.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"908_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jpsychires.2017.07.025","volume":"95","author":"A Panchaud","year":"2017","unstructured":"Panchaud A, Hernandez-Diaz S, Freeman MP, et al. Use of atypical antipsychotics in pregnancy and maternal gestational diabetes. J Psychiatr Res. 2017;95:84\u201390. https:\/\/doi.org\/10.1016\/j.jpsychires.2017.07.025.","journal-title":"J Psychiatr Res"},{"key":"908_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2298","volume":"350","author":"SN Vigod","year":"2015","unstructured":"Vigod SN, Gomes T, Wilton AS, et al. Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ. 2015;350: h2298. https:\/\/doi.org\/10.1136\/bmj.h2298.","journal-title":"BMJ"},{"issue":"10","key":"908_CR35","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/ph6101221","volume":"6","author":"B Kallen","year":"2013","unstructured":"Kallen B, Borg N, Reis M. The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel). 2013;6(10):1221\u201386. https:\/\/doi.org\/10.3390\/ph6101221.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"908_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1192\/bjp.bp.107.041541","volume":"192","author":"JJ Newham","year":"2008","unstructured":"Newham JJ, Thomas SH, MacRitchie K, et al. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry. 2008;192(5):333\u20137. https:\/\/doi.org\/10.1192\/bjp.bp.107.041541.","journal-title":"Br J Psychiatry"},{"key":"908_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003062","author":"A Sadowski","year":"2013","unstructured":"Sadowski A, Todorow M, Yazdani Brojeni P, et al. Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. BMJ Open. 2013. https:\/\/doi.org\/10.1136\/bmjopen-2013-003062.","journal-title":"BMJ Open"},{"issue":"9","key":"908_CR38","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1517\/14656566.2015.1041501","volume":"16","author":"J Kulkarni","year":"2015","unstructured":"Kulkarni J, Storch A, Baraniuk A, et al. Antipsychotic use in pregnancy. Expert Opin Pharmacother. 2015;16(9):1335\u201345. https:\/\/doi.org\/10.1517\/14656566.2015.1041501.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"908_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.schres.2014.07.034","volume":"159","author":"I Petersen","year":"2014","unstructured":"Petersen I, McCrea RL, Osborn DJP, et al. Discontinuation of antipsychotic medication in pregnancy: a cohort study. Schizophr Res. 2014;159(1):218\u201325. https:\/\/doi.org\/10.1016\/j.schres.2014.07.034.","journal-title":"Schizophr Res"},{"issue":"12","key":"908_CR40","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","volume":"164","author":"AC Viguera","year":"2007","unstructured":"Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164(12):1817\u201324. https:\/\/doi.org\/10.1176\/appi.ajp.2007.06101639.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"908_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1017\/neu.2016.60","volume":"29","author":"ER Larsen","year":"2017","unstructured":"Larsen ER, Saric K. Pregnancy and bipolar disorder: the risk of recurrence when discontinuing treatment with mood stabilisers: a systematic review. Acta Neuropsychiatr. 2017;29(5):259\u201366. https:\/\/doi.org\/10.1017\/neu.2016.60.","journal-title":"Acta Neuropsychiatr."},{"key":"908_CR42","unstructured":"EpC. The Swedish Medical Birth Register: a summary of content and quality. https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/ovrigt\/2003-112-3_20031123.pdf. Accessed 9 Nov 2020."},{"issue":"7","key":"908_CR43","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Michaelfored C, et al. The new Swedish Prescribed Drug Register: opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335. https:\/\/doi.org\/10.1002\/pds.1294.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"908_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.seizure.2017.03.007","volume":"48","author":"HS Sidhu","year":"2017","unstructured":"Sidhu HS, Srinivas R, Sadhotra A. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: a prospective study. Seizure. 2017;48:15\u201321. https:\/\/doi.org\/10.1016\/j.seizure.2017.03.007.","journal-title":"Seizure."},{"issue":"7","key":"908_CR45","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1651-2227.1996.tb14164.x","volume":"85","author":"K Mar\u0161\u00e1l","year":"1996","unstructured":"Mar\u0161\u00e1l K, Persson PH, Larsen T, et al. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85(7):843\u20138. https:\/\/doi.org\/10.1111\/j.1651-2227.1996.tb14164.x.","journal-title":"Acta Paediatr"},{"issue":"6","key":"908_CR46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1586\/17474108.3.6.719","volume":"3","author":"S Reeves","year":"2008","unstructured":"Reeves S, Bernstein I. Effects of maternal tobacco-smoke exposure on fetal growth and neonatal size. Expert Rev Obstet Gynecol. 2008;3(6):719\u201330. https:\/\/doi.org\/10.1586\/17474108.3.6.719.","journal-title":"Expert Rev Obstet Gynecol."},{"issue":"Suppl. 1","key":"908_CR47","first-page":"20","volume":"68","author":"JW Newcomer","year":"2007","unstructured":"Newcomer JW. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry. 2007;68(Suppl. 1):20\u20137.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"908_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.amepre.2008.11.020","volume":"36","author":"DB Allison","year":"2009","unstructured":"Allison DB, Newcomer JW, Dunn AL, et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med. 2009;36(4):341\u201350. https:\/\/doi.org\/10.1016\/j.amepre.2008.11.020.","journal-title":"Am J Prev Med"},{"issue":"3","key":"908_CR49","first-page":"e542","volume":"21","author":"I Nulman","year":"2014","unstructured":"Nulman I. The effects of the new antipsychotic medications on mothers and babies. J Popul Ther Clin Pharmacol. 2014;21(3):e542\u20137.","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"7","key":"908_CR50","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/pcn.12856","volume":"73","author":"S Gentile","year":"2019","unstructured":"Gentile S, Fusco ML. Schizophrenia and motherhood. Psychiatry Clin Neurosci. 2019;73(7):376\u201385. https:\/\/doi.org\/10.1111\/pcn.12856.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"908_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094788","volume":"9","author":"J Kulkarni","year":"2014","unstructured":"Kulkarni J, Worsley R, Gilbert H, et al. A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies. PLoS ONE. 2014;9(5): e94788. https:\/\/doi.org\/10.1371\/journal.pone.0094788.","journal-title":"PLoS ONE"},{"issue":"5","key":"908_CR52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/JCP.0000000000000391","volume":"35","author":"N Terrana","year":"2015","unstructured":"Terrana N, Koren G, Pivovarov J, et al. Pregnancy outcomes following in utero exposure to second-generation antipsychotics: a systematic review and meta-analysis. J Clin Psychopharmacol. 2015;35(5):559\u201365. https:\/\/doi.org\/10.1097\/JCP.0000000000000391.","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"908_CR53","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamainternmed.2021.4571","volume":"181","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chan AYL, Coghill D, et al. Association between prenatal exposure to antipsychotics and attention-deficit\/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age. JAMA Intern Med. 2021;181(10):1332. https:\/\/doi.org\/10.1001\/jamainternmed.2021.4571.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"908_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1471-2393-14-185","volume":"14","author":"M Lindqvist","year":"2014","unstructured":"Lindqvist M, Persson M, Lindkvist M, et al. No consensus on gestational diabetes mellitus screening regimes in Sweden: pregnancy outcomes in relation to different screening regimes 2011 to 2012, a cross-sectional study. BMC Pregnancy Childbirth. 2014;14(1):185. https:\/\/doi.org\/10.1186\/1471-2393-14-185.","journal-title":"BMC Pregnancy Childbirth"},{"key":"908_CR55","unstructured":"Socialstyrelsen. Gr\u00e4nsv\u00e4rden f\u00f6r graviditetsdiabetes. 2015."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-022-00908-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-022-00908-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-022-00908-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:27:14Z","timestamp":1652228834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-022-00908-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,26]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1007\/s40263-022-00908-2","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,26]]},"assertion":[{"value":"17 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Funding for this article was received from Region Stockholm, ALF project number 573301 (EH, KW, LF), Department of\u00a0Neonatology at Karolinska University Hospital, General Maternity Hospital Foundation, Samaritan Foundation for Paediatric Research, Lilla Barnets Fond (EH), and Sven Jerring Foundation (LF). The funders did not take part in conducting the research or writing the paper.\u00a0Open access funding was\u00a0provided by Karolinska Institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"EH, LF, UN, KW and KK declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Regional Ethical Review Board in Lund (dnr. 2013\/342-31\/5).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data from the Swedish registers are protected, but some aggregated data can be available on request from the authors.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"KK conceptualized and designed the study, was responsible for the data collection, carried out the initial analyses, and reviewed and revised the manuscript. EH conceptualized and designed the study and drafted the initial manuscript. UN, LF and KW conceptualized and designed the study and critically reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work outlined in the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}